Revenue
2012
2013
2014
2015
2017
2018
2019
2020
2021
2022
2023
2024
2025
Ardelyx, Inc. (ARDX)
Price$3.73Cached quote
Net income
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $407.3M | $333.6M | $124.5M | $52.2M | $10.1M | $7.6M | $5.3M | $2.6M | $42.0M | — | $24.0M | $31.6M | $28.9M | $5.4M |
| Gross profit | $367.8M | $283.1M | $106.7M | $48.0M | $9.1M | $7.4M | $4.7M | $2.1M | $33.6M | — | $24.0M | — | — | — |
| Gross margin | 90.29% | 84.85% | 85.70% | 92.11% | 90.10% | 98.08% | 88.64% | 82.13% | 80.00% | — | 100.00% | — | — | — |
| Research & development | $71.5M | $52.3M | $35.5M | $35.2M | $91.1M | $65.1M | $71.7M | $69.4M | $75.5M | $94.2M | $39.9M | $25.9M | $28.1M | $10.2M |
| Operating expenses | $448.3M | $361.6M | $187.7M | $115.9M | $164.4M | $98.4M | $96.5M | $93.6M | $98.7M | $112.9M | $53.4M | $33.2M | $31.8M | $14.2M |
| Operating income | −$41.0M | −$27.9M | −$63.3M | −$63.8M | −$154.3M | −$90.8M | −$91.3M | −$90.9M | −$65.1M | −$112.9M | −$29.4M | −$1.6M | −$2.9M | −$8.8M |
| Operating margin | −10.06% | −8.38% | −50.84% | −122.24% | −1,528.63% | −1,199.05% | −1,728.14% | −3,488.57% | −155.04% | — | −122.32% | −4.95% | −9.90% | −162.75% |
| EBITDA | −$37.9M | −$25.9M | −$62.0M | −$62.6M | −$151.5M | −$88.2M | −$88.8M | −$88.2M | −$62.5M | −$111.6M | −$28.6M | −$1.3M | −$2.3M | −$8.1M |
| EBITDA margin | −9.31% | −7.76% | −49.80% | −120.05% | −1,500.83% | −1,165.49% | −1,680.80% | −3,385.00% | −148.85% | — | −118.99% | −4.00% | −7.83% | −150.28% |
| Net income | −$61.6M | −$39.1M | −$66.1M | −$67.2M | −$158.2M | −$94.3M | −$94.9M | −$91.3M | −$64.3M | −$112.4M | −$29.6M | −$3.2M | −$6.6M | −$9.8M |
| Net profit margin | −15.12% | −11.73% | −53.08% | −128.85% | −1,566.46% | −1,245.71% | −1,797.77% | −3,502.03% | −153.19% | — | −123.29% | −10.16% | −22.69% | −180.87% |
| Basic EPSper basic share | -$0.26 | -$0.17 | -$0.30 | -$0.42 | -$1.52 | -$1.05 | -$1.47 | -$1.62 | -$1.36 | -$2.80 | -$1.29 | -$0.31 | -$5.82 | -$11.32 |
| Diluted EPSper diluted share | -$0.26 | -$0.17 | -$0.30 | -$0.42 | -$1.52 | -$1.05 | -$1.47 | -$1.62 | -$1.36 | -$2.80 | -$1.29 | -$0.31 | -$5.82 | -$11.32 |
Owners
Reported shareholders
9.43%of listed shares
BlackRock, Inc.23.5M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
BlackRock, Inc. | 9.43%23.5M shares |
Rubric Capital Management LP | 6.50%16.2M shares |
MILLENNIUM MANAGEMENT LLC | 5.58%13.9M shares |
STATE STREET CORP | 5.36%13.36M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 4.20%10.47M shares |
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 3.83%9.55M shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | 3.22%8.03M shares |
GEODE CAPITAL MANAGEMENT, LLC | 2.57%6.4M shares |
Jupiter Topco LLC | 2.13%5.3M shares |
TWO SIGMA INVESTMENTS, LP | 2.09%5.21M shares |
Nuveen, LLC | 1.60%4M shares |
GOLDMAN SACHS GROUP INC | 1.48%3.69M shares |
MOTT DAVID M | ≈1.34%3.35M shares |
AIGH Capital Management LLC | 1.28%3.2M shares |
MORGAN STANLEY | 0.96%2.39M shares |
AQR CAPITAL MANAGEMENT LLC | 0.93%2.32M shares |
NORTHERN TRUST CORP | 0.92%2.28M shares |
Rock Springs Capital Management LP | 0.90%2.24M shares |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.89%2.21M shares |
BANK OF AMERICA CORP /DE/ | 0.87%2.16M shares |
Percentages use 249.15M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 18, 2026Form 4 · 10b5-1 | Williams Laura AChief Patient Officer | SellCommon Stock | 81.9K | $5.99 | $490.6K | 378.2K |
| Jun 15, 2026Form 4 · 10b5-1 | RAAB MICHAELPresident & CEO | SellCommon Stock | 41.7K | $5.67 | $236.2K | 1.70M |
| May 21, 2026Form 4 | Hohenleitner SusanChief Financial Officer | SellCommon Stock | 1.5K | $6.27 | $9.1K | 229.1K |
| May 21, 2026Form 4 | Brady James ParkerChief Human Resources Officer | SellCommon Stock | 1.8K | $6.27 | $11.6K | 261.1K |
| May 21, 2026Form 4 | Reilly Joseph JamesSee Remarks | SellCommon Stock | 1.0K | $6.27 | $6.5K | 149.8K |